(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(14),7(12),8,10,15,17-hexaene; maleic acid | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(14),7(12),8,10,15,17-hexaene; maleic acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 14 USDMF, 1 JDMF, 5 EU WC, 7 NDC API, 12 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

28 FDF Dossiers, 14 FDA Orange Book, 8 Europe, 2 Canada, 2 Australia, 2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;SUBLINGUAL - EQ 10MG BASE, TABLET;SUBLINGUAL - EQ 2.5MG BASE, TABLET;SUBLINGUAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 12 SPI Pharma, 4 DKSH, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Pfanstiehl, 4 ACG Worldwide, 1 BASF, 1 Bioplus Life Sciences, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 2 Pluviaendo, 1 Qualicaps, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 11 Taste Masking, 10 Chewable & Orodispersible Aids, 9 Direct Compression, 8 Empty Capsules, 5 Thickeners and Stabilizers, 4 Co-Processed Excipients, 4 Parenteral, 3 Disintegrants & Superdisintegrants, 3 Granulation, 1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 6 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

39 US Patents, 4 Health Canada Patents

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

5 All

01 5Saphris

List of Suppliers

Product Main Page

01

Brand Name : Saphris

CPhI India 2024

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 155

2016 Revenue in Millions : 167

Growth (%) : -7

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Saphris

CPhI India 2024

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 140

2017 Revenue in Millions : 155

Growth (%) : -10%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Saphris

CPhI India 2024

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 167

2015 Revenue in Millions : 187

Growth (%) : -11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Saphris

CPhI India 2024

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 135

2018 Revenue in Millions : 140

Growth (%) : -3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Saphris

CPhI India 2024

Not Confirmed

Contact us
to update this info